Work

A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours

Year: 2014

Type: article

Study design: Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2013.12.006

Authors: Antoine Hollebecque, Nadine Houédé, Ezra E.W. Cohen, Christophe Massard, Antoine Italiano, Paul Westwood, William Bumgardner, Joel Miller, Les H. Brail, Karim A. Benhadji, Jean-Charles Soria

Institutions: Institut Gustave Roussy, Fondation Gustave Roussy, Centre Hospitalier Universitaire de Nîmes, Institut Bergonié, Institut de Recherche en Cancérologie de Montpellier, University of Chicago, Eli Lilly (United Kingdom), Eli Lilly (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2091819675

FWCI: 1.639

Cites: 20

Cited by: 34

Related to: 10